Meet the editor

Henry Soo-Min Park, MD, MPH, is a board-certified radiation oncologist who currently serves as Assistant Professor of Therapeutic Radiology and Chief of Thoracic Radiotherapy at the Yale School of Medicine. He also serves as the department's Director of Continuing Medical Education, the Medical Student Clerkship, and the Yale Radiation Oncology Consortium e(focusing on comparative effectiveness and health services research), as

well as associate director of the residency program. Dr. Park received his undergraduate degree from Yale College, master's degree from Harvard School of Public Health, and MD from Yale School of Medicine. He completed his internal medicine internship at Harvard Medical School's Beth Israel Deaconess Medical Center and returned to Yale New Haven Hospital for his residency and chief residency in radiation oncology.

Contents

**Section 1**

**Section 2**

**Section 3**

The Value of Multiple Perspectives

*by Güntuğ Batihan and Kenan Can Ceylan*

*by Andrew X. Li and Justin D. Blasberg*

Radiotherapy: An Alternative to Surgery

Current Status and Future Perspectives *by Hiroshi Doi and Kozo Kuribayashi*

Image-Guided Ablative Therapies for Lung Tumors *by Joyce W.Y. Chan, Rainbow W.H. Lau and Calvin S.H. Ng*

Robotic Surgery for Non-Small Cell Lung Cancer

*by Henry Soo-Min Park*

**Preface XI**

Introduction **1**

**Chapter 1 3**

Surgical Advances **9**

**Chapter 2 11**

**Chapter 3 27**

Radiotherapeutic and Ablative Technology **41**

**Chapter 4 43**

**Chapter 5 63** Definitive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer:

**Chapter 6 81**

*by Paul Van Houtte, Charlier Florian, Luigi Moretti and Dirk Van Gestel*

The Role of Minimally Invasive Surgery in the Treatment of Lung Cancer

Introductory Chapter: Recent Progress in Lung Cancer Treatment -

## Contents



Preface

Lung cancer management has undergone revolutionary changes in recent years. This book introduces the reader to some of the most relevant and exciting advances in the field. The book begins with a discussion of minimally invasive surgical techniques followed by a review of the progress in nonoperative therapies like radiotherapy and ablation. Next, the book examines systemic therapy that has moved well beyond standard cytotoxic chemotherapy and that can often be combined with local therapies even for metastatic disease. Finally, the book presents several newer diagnostic and therapeutic tools that have not yet become

This book is dedicated to patients with lung cancer who have contributed to the acquisition and consolidation of knowledge by consenting to data collection through clinical trials or registries. By comprehensively reviewing the most impactful innovations of the modern era, we hope to inspire you to imagine what

**Henry S. Park, MD, MPH**

Yale School of Medicine, New Haven, CT, USA

Department of Therapeutic Radiology,

mainstream.

might be possible in the near future.
